Albumin reduces the risk of death in children with severe malaria and acidosis in a Phase II randomised controlled trial of volume expansion [MIM-KM-16564]

MLA

Maitland, K., et al. Albumin Reduces the Risk of Death in Children with Severe Malaria and Acidosis in a Phase II Randomised Controlled Trial of Volume Expansion [MIM-KM-16564]. July 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..d67b41f97c7e055c37f92b70de3c196a&authtype=sso&custid=ns315887.

APA

Maitland, K., Pamba, A., English, M., Peshu, N., Levin, M., Marsh, K., & Newton, C. (2016). Albumin reduces the risk of death in children with severe malaria and acidosis in a Phase II randomised controlled trial of volume expansion [MIM-KM-16564].

Chicago

Maitland, K, A Pamba, M English, N Peshu, M Levin, K Marsh, and C Newton. 2016. “Albumin Reduces the Risk of Death in Children with Severe Malaria and Acidosis in a Phase II Randomised Controlled Trial of Volume Expansion [MIM-KM-16564],” July. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..d67b41f97c7e055c37f92b70de3c196a&authtype=sso&custid=ns315887.